Document Detail

LKB1 and AMPK: central regulators of lymphocyte metabolism and function.
MedLine Citation:
PMID:  22889215     Owner:  NLM     Status:  In-Data-Review    
When T cells encounter foreign antigen and appropriate costimulatory signals from professional antigen-presenting cells (APCs), they initiate a coordinated program of rapid proliferation and differentiation, leading to the development of activated T cells with specific effector functions tailored toward pathogen clearance or control. One of the fundamental programs that underpin T-cell proliferation and function is the regulation of cellular metabolism. Recent efforts to identify the signal transduction pathways that regulate T-cell metabolism have led to the identification of liver kinase B1 (LKB1) and AMP-activated protein kinase (AMPK) as key regulators of T-cell metabolism. LKB1 and AMPK are part of an evolutionarily conserved signal transduction pathway that monitors cellular energy status. AMPK senses bioenergetic fluctuations in cells and works in concert with LKB1 to maintain cellular energy homeostasis by promoting catabolic pathways of ATP production and limiting processes that consume ATP. Recent data indicate that LKB1 and AMPK can influence diverse aspects of T-cell biology beyond metabolism, including T-cell development, peripheral T-cell homeostasis, and T-cell effector function. In this review, we focus on the regulation of lymphocyte metabolism by this energy-sensing pathway and discuss its influence on T-cell function.
Julianna Blagih; Connie M Krawczyk; Russell G Jones
Related Documents :
2781965 - Cytologic diagnosis of a case of recurrent adamantinoma.
22524215 - Experimental investigation of the cytotoxicity of medium-borne signals in human prostat...
2548945 - Anaplastic large cell ki-1 lymphoma. delineation of two morphological types.
21487605 - A genome-wide rnai screen identifies novel targets of neratinib sensitivity leading to ...
2507635 - Characterization of t cell antigens associated with the cell wall protein-peptidoglycan...
19118885 - Antitumor effects of an imidazoquinoline in renal cell carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Immunological reviews     Volume:  249     ISSN:  1600-065X     ISO Abbreviation:  Immunol. Rev.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7702118     Medline TA:  Immunol Rev     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  59-71     Citation Subset:  IM    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Department of Physiology, McGill University, Montreal, Quebec; Goodman Cancer Research Centre, McGill University, Montreal, Quebec.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  mTOR, metabolism, and the regulation of T-cell differentiation and function.
Next Document:  Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis ...